Slide 1: Q1 FY26 Result Presentation
Q1 FY26 Result Presentation 31 October 2025 Mach7 Technologies | ASX: M7T
Slide 2: Mach7 Technologies delivers advanced image data management and diagnostic viewing solutions
Mach7 Technologies delivers advanced image data management and diagnostic viewing solutions to healthcare organisations worldwide.
Slide 3: Q1 FY26 Financial Highlights
Q1 FY26 Financial Highlights Reset quarter as we begin to execute a full commercial transformation. VHA NTP initial go-live A$29.6M A$23.5M CARR1 ARR2 Run Rate Phase 1 limited go-live -A$0.4M on 30 Jun 2025 +A$0.1M on 30 June 2025 In constant currency In constant currency A$18.9M A$2.6M Lower staff
Slide 4: Strategic directions
Strategic directions From archive to architecture. The imaging industry is undergoing rapid change, costs are soaring, talent is scarce, and data silos persist. Agentic AI is emerging as the catalyst for 1 efficiency, innovation, and opportunities for Mach7 to capture market leadership. 49% Mach7’s
Slide 5: Market opportunity
Market opportunity Uniquely positioned to capitalise on VNA architecture, AI-ready interoperability and price-to-performance advantage. Healthcare Enterprise AI in medical Rapid growth in experiencing imaging market imaging is radiology, data explosion projected to fastest growing cardiology, drivin
Slide 6: Product and innovation roadmap
Product and innovation roadmap New Additional architecture eUnity expansion capabilities launch Enable Agentic AI through open Evolution of eUnity into a full tele- Embedding telemetry and AI-driven APIs that unify data flow, imaging platform, uniting radiology, optimisation across deployments to em
Slide 7: Asia: from quiet outpost to strategic growth engine
Asia: from quiet outpost to strategic growth engine 1 Establishing a low-cost innovation hub. Capitalising on VNA growth in Asia and the Middle East leveraging our impending CE Mark and regional 2 position for capital sales in enterprise and government 49% 58% 32% opportunities globally. 32% Establi
Slide 8: Operating model and framework
Operating model and framework Purpose and Value Agenda Purpose anchors decisions to improve patient care; value agenda aligns resources to customer outcomes and monetisation models. Organisational Structure Structure empowers accountable mission teams supported by AI-enabled execution, restructured
Slide 9: Commercial transformation and innovation
Commercial transformation and innovation Driving profitable growth through innovation, execution and accountability. • Comprehensive leadership refresh – Realigned leadership to boost execution, innovation and sustainable growth with sharper focus and accountability. 49% 58% 32% • Commercial transfo
Slide 10: Transforming our customer engagement
Transforming our customer engagement Flight Crew - revitalising how Mach7 serves its customers and partners. One multi-disciplinary customer designated team Led by Advocate for Customer Experience (ACE) Clear accountability improves support response time Single point of accountability reduces time a
Slide 11: Mach7 CLIMBS culture code
Mach7 CLIMBS culture code Culture is the execution engine of our strategy. Customer First Principle Learn and Grow Innovate for Impact Minimise complexity and move Build with ownership Sell and grow together 11
Slide 12: Outlook
Outlook Mach7 is well positioned to execute its strategic ambitions with a refreshed leadership team driving technical, cultural, and operational changes. We strive to reshape how imaging data powers healthcare and to translate innovation into financial performance. Financial discipline remains cent
Slide 13: Contact Us
Contact Us Investor Relations, Mach7 Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 This document was authorised for release to the ASX by Teri Thomas, Managing Director and Chief Executive Officer Mach7 Technologies
Slide 14: Disclaimer
Disclaimer “Forward looking” statements Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities current as at the date